The Psoriasis (also known as psoriasis) is an inflammatory skin disease that is not contagious. Here, the immune system attacks the body's own tissue. A team led by Univ. Prof. Dr. Tamara Kopp from the MedUni Vienna has successfully used antibodies against the symptoms of psoriasis in a clinical study.

Treatment of psoriasis (Psoriasis)

As kleinezeitung.at reported, dermatologist Univ. Prof. Dr. Tamara Kopp from the JUVENIS cosmetic center in Vienna was able to show in a new study that the targeted blockade of a messenger substance in the immune system (interleukin-23/IL-23) significantly alleviates the symptoms of psoriasis.

A total of 77 patients (with moderate to severe symptoms of psoriasis) were injected with different doses of the antibody “Tildrakizumab” or a placebo preparation in a study. The skin of the patients treated with high doses was up to 100 percent free of the symptoms of psoriasis.

The Phase II study has meanwhile already been successfully completed and is now in the clinical Phase-III trial. The dose has already been determined and it is no longer administered intravenously, but only under the skin (subcutaneously). The study is now in the final stage before possible approval.

Further treatments for healthy skin in Vienna at JUVENIS

In addition to treatments for healthy skin in Vienna, JUVENIS offers additional services related to Health & preventive care, Radiance & posture as well as Outer beauty that make you outwardly radiant and enhance your well-being.

The article can be read in the latest issue on kleinezeitung.at.
The study: “Clinical improvement in psoriasis with specific targeting of interleukin-23”, Nature (9.3.2015; doi: 10.1038/nature14175).